BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2014
View Archived Issues
Shire's candidate for dystrophic epidermolysis bullosa receives FDA orphan drug status
Read More
FDA grants orphan drug status to ovarian cancer and CLL treatments
Read More
miRNA levels associated with response to cisplatin in metastatic bladder cancer patients
Read More
Medimetriks Pharmaceuticals licenses ozenoxacin from Ferrer
Read More
GSK seeks Japanese approval of clindamycin/benzoyl peroxide gel for acne
Read More
Vertical Pharmaceuticals acquires Upsher-Smith women's health products
Read More
NeuroVive and A1M Pharma to collaborate on mitochondrial medicine research
Read More
Spark Therapeutics and Genable collaborate on GT-038 for RHO adRP
Read More
Cellular Biomedicine reports results from phase I study of TC-DC for liver cancer
Read More
Kamada advances development of inhaled AAT therapy for AATD
Read More
GNAS gene mutations identified in spectrum of pancreatic carcinomas
Read More
Kaketsuken announces Japanese approval of cell culture pandemic influenza vaccine
Read More
Tofogliflozin hydrate approved for type 2 diabetes in Japan
Read More
Russia approves simeprevir for chronic hepatitis C genotype 1 infection
Read More
Results presented for the novel xanthine oxidase inhibitor LC-350189 in humans
Read More
Exelixis receives E.U. approval for Cometriq for medullary thyroid carcinoma
Read More
Gilead presents in vivo results for GS-9973
Read More
The University of Exeter presents new photodynamic agents for cancer
Read More
Rockwell Medical seeks FDA approval of Triferic
Read More
Novel SUMO-1 activators presented for heart failure and other disorders
Read More
Samsca approved in Japan for autosomal dominant polycystic kidney disease
Read More
Alectos Therapeutics and Merck & Co. patent novel glycosidase inhibitors
Read More
DMC recommends continuation of pivotal study of Firdapse for LEMS
Read More
Epilepsy Awareness Day: Personalized therapy options for early-onset epileptic encephalopathy
Read More
Nippon Shinyaku divulges novel mGlu5 receptor antagonists
Read More
Ariad begins phase II trial of AP-26113 for ALK+ refractory NSCLC
Read More
Japanese approval obtained for Sandoz's biosimilar filgrastim
Read More